Temporal trends in the hospitalization and outcomes of patients with decompensated heart failure Multicenter study

Int J Cardiol. 2011 Mar 3;147(2):265-70. doi: 10.1016/j.ijcard.2009.09.526. Epub 2009 Nov 8.

Abstract

Background: The burden of illness of heart failure (HF) may be changing. We performed a study to define temporal trends in hospital admissions and long-term mortality among patients admitted with acute decompensated heart failure.

Methods: We studied consecutive admissions with HF as a primary diagnosis at seven hospitals from 2000 to 2004. Admissions with a concurrent acute myocardial infarction were excluded from the analysis. Temporal trends in the etiology of HF, associated co-morbid conditions, medications and mortality were identified.

Results: A total of 21,581 hospitalizations of 12,769 patients with primary diagnosis of HF were studied (average age 75). Monthly admission rate decreased by 10% over the study period, primarily due to a decrease in HF admissions of IHD etiology. Between 2000 and 2004 there was a significant increase in post-discharge purchase of beta-blockers (from 44.0% to 69.0%, p < 0.001) and statins (from 27.1% to 47.5%, p < 0.001). Mortality at 18 months post-discharge decreased from 38.9% to 33.9%. Multivariable analysis demonstrated that an annual mortality hazard decline could be explained by an increase in beta-blocker and statin use.

Conclusions: The admission of acute HF patients of IHD, but not non-IHD etiology declined throughout the study period. Short term mortality remained stable throughout the study period, while there was a significant improvement in 18 month mortality rates. This reduction can be explained by higher utilization of the health services as can be manifested by an increase in statins and beta-blockers use.

Publication types

  • Multicenter Study

MeSH terms

  • Acute Disease
  • Adrenergic beta-Antagonists / therapeutic use
  • Aged
  • Aged, 80 and over
  • Comorbidity
  • Female
  • Follow-Up Studies
  • Health Care Surveys
  • Heart Failure / drug therapy
  • Heart Failure / mortality*
  • Hospitalization / statistics & numerical data*
  • Hospitalization / trends*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Male
  • Middle Aged
  • Myocardial Ischemia / drug therapy
  • Myocardial Ischemia / mortality*
  • Outcome Assessment, Health Care / statistics & numerical data*

Substances

  • Adrenergic beta-Antagonists
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors